Lower thromboembolic risk with new A-fib after CABG versus NVAF

Lower thromboembolic risk with new A-fib after CABG versus NVAF

(HealthDay)—For patients post coronary artery bypass graft (CABG) surgery, new-onset postoperative atrial fibrillation (POAF) is associated with lower long-term thromboembolic risk than that seen among patients with nonvalvular atrial fibrillation (NVAF), according to a study published online March 28 in JAMA Cardiology.

Jawad H. Butt, M.D., from Copenhagen University Hospital in Denmark, and colleagues used data from a clinical cardiac surgery database and Danish nationwide registries to identify patients undergoing first-time isolated CABG surgery who developed new-onset POAF. A total of 2,108 patients who developed POAF were matched to 8,432 with NVAF.

The researchers found that oral therapy was initiated within 30 days post-discharge in 8.4 and 42.9 percent of those with POAF and NVAF, respectively. The POAF group had a significantly lower risk of thromboembolism (18.3 versus 29.7 events per 1,000 person-years; adjusted hazard ratio, 0.67). In both patients with POAF and NVAF, anticoagulation therapy during follow-up was associated with reduced risk of thromboembolic events (adjusted hazard ratios, 0.55 and 0.59, respectively) compared to patients who did not receive any . The risk of thromboembolism was not significantly higher in with POAF versus those who did not develop POAF.

"These data do not support the notion that new-onset POAF should be regarded as equivalent to primary NVAF in terms of long-term thromboembolic ," the authors write.

Several authors disclosed financial ties to the pharmaceutical industry.

Explore further

Plasma catecholamines predict post-op A-fib after cardiac Sx

More information: Abstract/Full Text
Editorial (subscription or payment may be required)
Journal information: JAMA Cardiology

Copyright © 2018 HealthDay. All rights reserved.

Citation: Lower thromboembolic risk with new A-fib after CABG versus NVAF (2018, March 30) retrieved 16 June 2021 from https://medicalxpress.com/news/2018-03-thromboembolic-a-fib-cabg-nvaf.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Feedback to editors

User comments